Lindbrook Capital’s Crinetics Pharmaceuticals CRNX Stock Holding History

Lindbrook Capital’s Portfolio CRNX Stock Details CRNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$12.1K	Buy
2024 Q4	$17.2K	Sell
2024 Q3	$18.5K	Buy
2024 Q2	$15.9K	Buy
2024 Q1	$13K	Buy
2023 Q4	$1.17K	Sell
2023 Q3	$1.46K	Buy
2022 Q4	–	Sell
2022 Q3	$2K	Buy
2022 Q2	$2K	Buy
2022 Q1	$1K	Buy